Hypermarcas (OTCMKTS:HYPMY) Trading Down 5.7% – What’s Next?

Hypermarcas (OTCMKTS:HYPMY) was down 5.7% during trading on Monday . The stock traded as low as $3.96 and last traded at $3.96. Approximately 59,253 shares changed hands during mid-day trading, an increase of 140% from the average daily volume of 24,652 shares. The stock had previously closed at $4.20.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Hypermarcas currently has a consensus rating of “Buy”.

Hypermarcas Trading Down 5.7%

The company has a 50 day moving average of $4.53 and a 200 day moving average of $4.49. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27. The stock has a market capitalization of $2.79 billion, a price-to-earnings ratio of 8.25 and a beta of 0.70.

Hypermarcas (OTCMKTS:HYPMY) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The firm had revenue of $383.13 million during the quarter. On average, research analysts predict that Hypermarcas will post 0.53 EPS for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.